Where

This is an online event.

Contact

Duke-Margolis Events
Duke-Margolis Center for Health Policy
202-621-2800
margolisevents@duke.edu

Endpoint Considerations to Facilitate Drug Development for Niemann-Pick Type C (NPC)

In this workshop, participants will discuss clinical endpoints relevant to NPC clinical trials and innovative strategies to support therapeutic development for patients with NPC. January 24, 2022 - 12:00pm - 3:30pm January 25, 2022 - 12:00pm - 3:30pm You may submit comments for this workshop to Docket FDA-2021-N-1297. Docket open until 4/25/22

* Required information

Personal Information

  • *
  • *
  • *
  • *

Business Information

  • *
  • *

Yes, I would like to receive your email newsletters

Register